Download now: https://ow.ly/oAkW50SkgH3 Traditional #oncology marketing-oriented journeys neglect the increasing complexities and advancing technologies and treatments in the market. EVERSANA INTOUCH’s pioneering Tumor Journey Model considers all decision points, tumor characteristics and interactions to enable more effective marketing interventions.
EVERSANA’s Post
More Relevant Posts
-
Multiplexing -- imaging multiple reporters at the same time -- is a significant advantage of fluorescence over contrast agents and reporters in other modalities. CFT also takes a high-resolution picture of the tissue/anatomy that co-registers with the high-sensitivity fluorescence images. Science is hard enough: Take the guesswork out of localization! #cft #preclinical #fluorescence #imaging
Discover how Cryo-fluorescence tomography (CFT) shows high-resolution, 3D co-localization of tumor cells and drugs, expanding existing 2D in vivo imaging techniques. See what you're missing: https://bit.ly/3NpfbkJ #fluorescence #preclinicalresearch #preclinicalimaging #oncology #immunotherapy
-
-
Enhance your Molecular Tumor Board with datma.360 visualization tool that augments your EHR, integrating fragmented healthcare data (including omics, clinical and imaging data) that currently impedes comprehensive patient analysis. This facilitates actionable insights for personalized medicine and helps prevent gaps in patient care. Revolutionize how you manage complex molecular diagnostic data in oncology and experience the future of precision medicine with Molecular Tumor Boards powered by datma.360. Reach out for a demo today! #oncology #precisionmedicine #ai #healthcareinnovation #moleculartumorboards #genomics #tumorboard #datma
Cut prep time and increase tumor board efficiency! See how datma streamlines data collection, case presentations, and collaboration for more productive tumor boards. Calculate your potential time & cost savings either our new ROI calculator www.datma.com/roi #tumorboard #oncology #precisionmedicine
-
-
The Response Assessment in Neuro-Oncology (RANO) group provides various central nervous system-related tumor response criteria and guidance for assessments. In our on-demand webinar MERIT experts discuss the principles and recommendations of RANO response criteria for high grade glioma (HGG) and the imaging endpoint information that needs to be collected for #clinicaltrials. Watch now: https://lnkd.in/g79kJpq9 #oncology #medicalimaging #clinicalresearch #MERITCROwebinar #webinar #MERITCRO #YourClinicalEndpointExpert #oncologyresearch #oncologytrials
-
-
Cut prep time and increase tumor board efficiency! See how datma streamlines data collection, case presentations, and collaboration for more productive tumor boards. Calculate your potential time & cost savings either our new ROI calculator www.datma.com/roi #tumorboard #oncology #precisionmedicine
-
-
Discover how Cryo-fluorescence tomography (CFT) shows high-resolution, 3D co-localization of tumor cells and drugs, expanding existing 2D in vivo imaging techniques. See what you're missing: https://bit.ly/3NpfbkJ #fluorescence #preclinicalresearch #preclinicalimaging #oncology #immunotherapy
-
-
Learn from RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using irRECIST to assess tumor burden. https://lnkd.in/gasWCRZ6 #MedicalImaging #ClinicalTrials #ChooseCalyx #ASCO23
-
Learn from #RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using #irRECIST to assess tumor burden. https://lnkd.in/d2qZyzxv #MedicalImaging #ClinicalTrials #ChooseCalyx
-
Learn from Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using irRECIST to assess tumor burden. Read the blog and learn more at #ASCO2024, Booth 10098. https://lnkd.in/g8GdRaKn #MedicalImaging #ClinicalTrials #ChooseCalyx
-
-
Learn from #RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using #irRECIST to assess tumor burden. https://lnkd.in/dJv4rSd9 #MedicalImaging #ClinicalTrials #ChooseCalyx
-
Learn from #RECIST expert, Dr. Oliver Bohnsack how response evaluation in #Oncology research can be improved – and in many cases, fewer #ClinicalTrial patients lost – by using #irRECIST to assess tumor burden. https://lnkd.in/egb3tthg #MedicalImaging #ClinicalTrials #ChooseCalyx
